Selection, Thirty Day Outcome and Costs for Short Stay Endovascular Aortic Aneurysm Repair (SEVAR)
Selection, Thirty Day Outcome and Costs for Short Stay Endovascular Aortic Aneurysm Repair (SEVAR)
复制标题
DOI：
10.1016/j.ejvs.2012.02.031
复制
发表时间：
2012-06-01
影响因子：
5.7
通讯作者：
Varty, K.
中科院分区：
文献类型：
--
作者：
Al-Zuhir, N.;Wong, J.;Varty, K.
背景：主动脉瘤腔内修复术（EVAR）有可能缩短住院时间。本研究的目的是确定患者适合短期停留腹主动脉瘤腔内修复术（SEVAR）与一个单一的夜晚在hospital.Method和文件的结果：腹主动脉瘤腔内修复术患者进行了前瞻性评估SEVAR超过21个月的时间使用英国日间手术指南。关节麻醉和手术批准是必要的，这些患者被纳入这一血管通路。患者在手术当天入院，并在术后第二天出院，接受指定的护理方案。33例（33%）患者符合SEVAR标准，其中27例（81%）在术后1天成功出院。标准腹主动脉瘤腔内修复术组的总SEVAR中位LOS为1天（IQR = 0）与4天（IQR = 2）（P < 0.0001），成本从13，360（CI = 1074）降至9844（CI = 628）。研究期间SEVAR使用率的增加导致总体平均腹主动脉瘤腔内修复术成本降低，从12，102（CI磅= +/-795）降至10，330（CI磅= 757）。结论：SEVAR方案减少了选定患者的住院时间。来自更大的此类患者队列的结果需要进一步研究。这将确定SEVAR是否可以扩展到更多患者。(C)2012年欧洲血管外科学会。由爱思唯尔有限公司出版。保留所有权利。
Background: Endovascular Aortic aneurysm Repair (EVAR) offers the potential for a reduced hospital stay. The aim of this study was to identify patients suitable for short stay EVAR (SEVAR) with a single night in hospital and document their outcome.Method: Patients for EVAR were assessed prospectively for SEVAR over a 21-month period using UK Day Surgery Guidelines. Joint 'anaesthetic and surgical approval were necessary for these patients to be included in this vascular pathway. Patients were admitted on the day of surgery with a designated care protocol for discharge the day after.Results: 101 patients were assessed for SEVAR. 33 (33%) patients met the criteria for SEVAR and 27 of these (81%) were successfully discharged one day post-operatively. Total SEVAR median LOS was one day (IQR = 0) versus four days (IQR = 2) for the standard EVAR group (P < 0.0001) reducing costs from 13,360 (CI = 1074) to 9844 (CI = 628). Increased utilisation of SEVAR during the study period led to reduced overall average EVAR costs, 12,102(CI pound = +/-795) to 10,330(CI pound = 757).Conclusion: SEVAR protocol reduces hospital stay for selected patients. The outcomes from a larger cohort of such patients require further study. This would identify whether SEVAR could be expanded to more patients. (C) 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.